Schiff Nutrition has reached a preliminary agreement to pay at least $2 million to consumers who purchased arthritis care supplements the company promoted as effective in repairing and rebuilding joints wracked with the painful condition although no scientific evidence backs up the claims.
The company agreed on March 25 to settle a class action initiated in 2011 by plaintiffs who accused Schiff of making unsubstantiated and misleading claims about the medical value of its Move Free Advanced products, which retailed for about $30 each for 120 pills.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
